Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients

Diagn Pathol. 2011 Jun 3:6:47. doi: 10.1186/1746-1596-6-47.

Abstract

Background: Mucopolysaccharidosis type I (MPS I) is an autosomal storage disease resulting from defective activity of the enzyme α-L-iduronidase (IDUA). This glycosidase is involved in the degradation of heparan sulfate and dermatan sulfate. MPS I has severe and milder phenotypic subtypes.

Aim of study: This study was carried out on six newly collected MPS I patients recruited from many regions of Tunisia.

Patients and methods: Mutational analysis of the IDUA gene in unrelated MPS I families was performed by sequencing the exons and intron-exon junctions of IDUA gene.

Results: Two novel IDUA mutations, p.L530fs (1587_1588 insGC) in exon 11 and p.F177S in exon 5 and two previously reported mutations p.P533R and p.Y581X were detected. The patient in family 1 who has the Hurler phenotype was homozygous for the previously described nonsense mutation p.Y581X.The patient in family 2 who also has the Hurler phenotype was homozygous for the novel missense mutation p.F177S. The three patients in families 3, 5 and 6 were homozygous for the p.P533R mutation. The patient in family 4 was homozygous for the novel small insertion 1587_1588 insGC. In addition, eighteen known and one unknown IDUA polymorphisms were identified.

Conclusion: The identification of these mutations should facilitate prenatal diagnosis and counseling for MPS I in Tunisia.

MeSH terms

  • Child
  • Child, Preschool
  • DNA Mutational Analysis
  • Family Health
  • Female
  • Genotype
  • Humans
  • Iduronidase / genetics*
  • Male
  • Mucopolysaccharidosis I / enzymology
  • Mucopolysaccharidosis I / genetics*
  • Mucopolysaccharidosis I / pathology
  • Mutation, Missense*
  • Tunisia

Substances

  • Iduronidase